GlobeNewswire Inc. · Sep 27, 2024
Equasens: 2024 half-year results
Equasens Group's H1 2024 results were impacted by weaker economic conditions and continuing investment efforts, with revenue down 4.1% and current operating income down 24.1%. The Pharmagest, Axigate Link, and e-Connect divisions saw declines, while the Medical Solutions division underwent a transition period.

